EP4547201A4 - Verfahren zur vorbeugung und behandlung von chemotherapieinduzierter alopezie - Google Patents

Verfahren zur vorbeugung und behandlung von chemotherapieinduzierter alopezie

Info

Publication number
EP4547201A4
EP4547201A4 EP23832411.5A EP23832411A EP4547201A4 EP 4547201 A4 EP4547201 A4 EP 4547201A4 EP 23832411 A EP23832411 A EP 23832411A EP 4547201 A4 EP4547201 A4 EP 4547201A4
Authority
EP
European Patent Office
Prior art keywords
insucted
alopecia
chemotherapy
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23832411.5A
Other languages
English (en)
French (fr)
Other versions
EP4547201A1 (de
Inventor
Joaquin J Jimenez
John P Mccook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jjr&d LLC
Original Assignee
Jjr&d LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jjr&d LLC filed Critical Jjr&d LLC
Priority claimed from PCT/US2023/026780 external-priority patent/WO2024006550A1/en
Publication of EP4547201A1 publication Critical patent/EP4547201A1/de
Publication of EP4547201A4 publication Critical patent/EP4547201A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP23832411.5A 2022-07-01 2023-06-30 Verfahren zur vorbeugung und behandlung von chemotherapieinduzierter alopezie Pending EP4547201A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263357783P 2022-07-01 2022-07-01
PCT/US2023/026780 WO2024006550A1 (en) 2022-07-01 2023-06-30 Method of preventing and treating chemotherapy-induced alopecia

Publications (2)

Publication Number Publication Date
EP4547201A1 EP4547201A1 (de) 2025-05-07
EP4547201A4 true EP4547201A4 (de) 2025-10-29

Family

ID=95310063

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23832411.5A Pending EP4547201A4 (de) 2022-07-01 2023-06-30 Verfahren zur vorbeugung und behandlung von chemotherapieinduzierter alopezie

Country Status (1)

Country Link
EP (1) EP4547201A4 (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877209A (en) * 1996-11-07 1999-03-02 Yunis; Adel A. Hair follicle protective formulations
US7326420B2 (en) * 2001-03-06 2008-02-05 Burkhart Craig G Benzoyl peroxide compositions having increased potency
WO2011032159A1 (en) * 2009-09-14 2011-03-17 Meta Comestics, Llc Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
US20140243578A1 (en) * 2013-02-25 2014-08-28 Radiowave Therapy Research Institute Pty Ltd Radiowave treatment for cancer
US20190298719A1 (en) * 2016-11-15 2019-10-03 Novartis Ag Dose and regimen for hdm2-p53 interaction inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877209A (en) * 1996-11-07 1999-03-02 Yunis; Adel A. Hair follicle protective formulations
US7326420B2 (en) * 2001-03-06 2008-02-05 Burkhart Craig G Benzoyl peroxide compositions having increased potency
WO2011032159A1 (en) * 2009-09-14 2011-03-17 Meta Comestics, Llc Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
US20140243578A1 (en) * 2013-02-25 2014-08-28 Radiowave Therapy Research Institute Pty Ltd Radiowave treatment for cancer
US20190298719A1 (en) * 2016-11-15 2019-10-03 Novartis Ag Dose and regimen for hdm2-p53 interaction inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 4 January 2017 (2017-01-04), ANONYMOUS: "Rosemary Treatment Lotion", XP093305270, retrieved from https://www.gnpd.com/sinatra/recordpage/4506095/ Database accession no. 4506095 *
See also references of WO2024006550A1 *

Also Published As

Publication number Publication date
EP4547201A1 (de) 2025-05-07

Similar Documents

Publication Publication Date Title
EP4415755A4 (de) Ace2-gerichtete zusammensetzungen und verfahren zur behandlung von covid-19
EP4204443A4 (de) Verfahren und zusammensetzungen zur behandlung von glioblastom
EP4518846A4 (de) Zusammensetzungen und verfahren zur behandlung von epilepsie
EP4408412A4 (de) Zusammensetzungen und verfahren zur behandlung von kopfschmerzen
EP4171606A4 (de) Zusammensetzungen und verfahren zur behandlung von covid-19
EP4444244A4 (de) Verfahren und vorrichtung zur behandlung von myofaszialen punkten
EP4433044A4 (de) Verfahren und zusammensetzungen zur behandlung von kognitiver beeinträchtigung
EP3945077C0 (de) Verfahren und system zur behandlung von biofeststoffen
EP4340860A4 (de) Zusammensetzungen und verfahren zur behandlung von neuropathie
EP4188346A4 (de) Nobiletinzusammensetzungen und verfahren zur behandlung und prävention von covid-19 und verwandten erkrankungen
EP4114411A4 (de) Zusammensetzungen und verfahren zur behandlung von bauchspeicheldrüsenkrebs
EP4419144A4 (de) Zusammensetzungen und verfahren zur behandlung von muskeldystrophie
EP4217001A4 (de) Zusammensetzung und verfahren zur prävention und behandlung von hautstrahlungsschäden
EP4228696A4 (de) Zusammensetzungen und verfahren zur behandlung von bluterkrankungen
EP4518924A4 (de) System und verfahren zur behandlung von vorzeitigen föten
EP4395894A4 (de) Verfahren zur prävention und behandlung von synukleinopathien
EP4469559A4 (de) Zusammensetzungen und verfahren zur behandlung von mesothelinpositiven krebsarten
EP4323063A4 (de) Zusammensetzungen und verfahren zur behandlung von h-abc-leukodystrophie
EP4547201A4 (de) Verfahren zur vorbeugung und behandlung von chemotherapieinduzierter alopezie
EP4408532A4 (de) Zusammensetzungen und verfahren zur behandlung von pcdh19-bedingten erkrankungen
EP4415770A4 (de) Echogene zusammensetzungen und verfahren zur verwendung davon zur behandlung von schmerzen
EP4370654A4 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten ii
EP4405044A4 (de) Zusammensetzung und verfahren zur prävention und behandlung von hautstrahlungsschäden
EP4149436A4 (de) Zusammensetzungen und verfahren zur behandlung von wunden
EP4118210A4 (de) Behandlung von covid-19 und verfahren dafür

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20250926

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/22 20060101AFI20250922BHEP

Ipc: A61K 31/327 20060101ALI20250922BHEP

Ipc: A61K 31/381 20060101ALI20250922BHEP

Ipc: A61K 31/65 20060101ALI20250922BHEP

Ipc: A61P 17/14 20060101ALI20250922BHEP

Ipc: A61K 45/06 20060101ALI20250922BHEP

Ipc: A61Q 7/00 20060101ALI20250922BHEP

Ipc: A61K 33/40 20060101ALI20250922BHEP